logo
Dollar Tree Surpasses 9,000 Stores Across North America, Marking Major Growth Milestone

Dollar Tree Surpasses 9,000 Stores Across North America, Marking Major Growth Milestone

Business Wire15-05-2025

CHESAPEAKE, Va.--(BUSINESS WIRE)--Dollar Tree, Inc. (NASDAQ: DLTR) is proud to announce it has surpassed a major retail milestone with the opening of its 9,000 th store, reinforcing the company's position as one of the fastest-growing and most powerful value retailers in North America. With a footprint now spanning thousands of communities across the U.S. and Canada, this achievement reflects Dollar Tree's steadfast focus on delivering value, convenience, and 'thrill of the hunt' discovery in every aisle of every store. In celebration of this growth – and as a symbol of establishing roots in every community it serves – Dollar Tree is partnering with the Arbor Day Foundation to plant 9,000 trees across North America.
'Reaching 9,000 stores is a powerful indicator of the strength of our brand and the loyalty of our associates and customers,' said Mike Creedon, Chief Executive Officer, Dollar Tree, Inc.
From everyday essentials to unexpected delights, Dollar Tree is where shoppers come for unbeatable prices and leave with more than they expected. Whether it's stocking up on trusted brands or uncovering the latest seasonal find, the experience is all about the 'thrill of the hunt' – and with 9,000 stores and counting, that thrill is never far away.
'Reaching 9,000 stores is a powerful indicator of the strength of our brand and the loyalty of our associates and customers,' said Mike Creedon, Chief Executive Officer, Dollar Tree, Inc. 'It's also a testament to our profitable growth strategy, creating long-term value for our shareholders. And perhaps most importantly, every new Dollar Tree store helps us deliver on our promise to offer great value, convenience, and the 'thrill of the hunt' discovery for millions of families in North America.'
Dollar Tree is partnering with the Arbor Day Foundation to plant 9,000 trees in support of strategic reforestation efforts across eastern Texas, including within Davy Crockett National Forest and Sam Houston National Forest. Dollar Tree is committed to investing in opportunities that positively impact the well-being, resilience, and livability of the communities it serves. Through this partnership, the Arbor Day Foundation is helping to maximize that impact by providing ecological benefits for future generations and restoring vulnerable ecosystems that help support the health of nearby communities.
Dollar Tree will commemorate this achievement locally with a grand opening celebration at the official 9,000 th store in Plano, Texas. The 9,000 th Dollar Tree store, located at 5920 W. Park Blvd features the latest store format designed to enhance the shopping experience, with an expanded product selection and updated layouts to make it easier than ever to explore all that Dollar Tree has to offer. Locally, the first 100 customers to arrive at the new Plano store on Thursday, May 15 (5920 W. Park Blvd., Plano, TX 75093) will receive a $20 Dollar Tree gift card.
A WARNING ABOUT FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as that term is used in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they address future events, developments or results and do not relate strictly to historical facts. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements preceded by, followed by or including words such as: 'believe', 'anticipate', 'expect', 'intend', 'plan', 'view', 'target' or 'estimate', 'may', 'will', 'should', 'predict', 'possible', 'potential', 'continue', 'strategy', and similar expressions. For example, our forward-looking statements include statements relating to our plans and expectations regarding our business, growth strategy, long-term value, and other objectives and expectations. These statements are subject to risks and uncertainties. For a discussion of the risks, uncertainties and assumptions that could affect our future events, developments or results, you should carefully review the 'Risk Factors,' 'Business' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections in our Annual Report on Form 10-K filed March 26, 2025 and other filings we make from time to time with the Securities and Exchange Commission. We are not obligated to release publicly any revisions to any forward-looking statements contained in this press release to reflect events or circumstances occurring after the date of this report and you should not expect us to do so.
About Dollar Tree, Inc.
Dollar Tree, a Fortune 200 Company, operated 16,500 stores across 48 states and five Canadian provinces as of February 1, 2025. Stores operate under the brands of Dollar Tree, Family Dollar, and Dollar Tree Canada. To learn more about the Company, visit www.DollarTree.com.
About Arbor Day Foundation
The Arbor Day Foundation is a global nonprofit inspiring people to plant, nurture, and celebrate trees. They foster a growing community of more than 1 million leaders, innovators, planters, and supporters united by their bold belief that a more hopeful future can be shaped through the power of trees. For more than 50 years, they've answered critical need with action, planting more than half a billion trees alongside their partners. And this is only the beginning. The Arbor Day Foundation is a 501(c)(3) nonprofit pursuing a future where all life flourishes through the power of trees. Learn more at arborday.org.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why CrowdStrike (CRWD) Stock Is Falling Today
Why CrowdStrike (CRWD) Stock Is Falling Today

Yahoo

time7 minutes ago

  • Yahoo

Why CrowdStrike (CRWD) Stock Is Falling Today

Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) fell 5.5% in the afternoon session after the company reported mixed first quarter 2025 (Q1 FY-26) results: its revenue guidance for next quarter slightly missed and its full-year revenue guidance was just in line with Wall Street's estimates. On the other hand, CrowdStrike beat convincingly on operating profit. Looking ahead, guidance was solid. The company's EPS guidance for next quarter topped analysts' expectations, and its full-year EPS guidance slightly exceeded Wall Street's estimates as well. Overall, this was a mixed quarter and not enough for the high expectations around the stock (as evidenced by the 52-week high right before reporting and a 40+% stock price appreciation year-to-date before the print). The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy CrowdStrike? Access our full analysis report here, it's free. CrowdStrike's shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 11 months ago when the stock dropped 14.7% following a global technology outage. The outage was caused by a faulty update deployed by CrowdStrike to computers running the Microsoft Windows operating system. CrowdStrike clarified that the issue wasn't caused by "a security incident or cyberattack." CEO George Kurtz noted on the social media platform X (formerly called Twitter) that "the issue has been identified, isolated, and a fix has been deployed." However, the issue had far-reaching consequences, affecting systems in industries delivering critical services, including hospitals, banks, and airports. CRWD stock's decline suggested markets might be struggling to understand the long-term implications of the issue, especially as it relates to CrowdStrike maintaining its dominance in the highly competitive cybersecurity space, which often permits little to no room for mistakes. Wedbush analyst Dan Ives provided insights on how this might play out, adding, "It could create opportunity for some competitive displacements, but this will take time to determine the path of CIOs and companies looking ahead and related legal actions related to this outage." CrowdStrike is up 33% since the beginning of the year, and at $461.84 per share, it is trading close to its 52-week high of $488.76 from June 2025. Investors who bought $1,000 worth of CrowdStrike's shares 5 years ago would now be looking at an investment worth $4,812. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Donaldson's Q3 Earnings Beat Estimates, Sales Increase Y/Y
Donaldson's Q3 Earnings Beat Estimates, Sales Increase Y/Y

Yahoo

time7 minutes ago

  • Yahoo

Donaldson's Q3 Earnings Beat Estimates, Sales Increase Y/Y

Donaldson Company, Inc. DCI reported third-quarter fiscal 2025 (ended April 30, 2025) adjusted earnings of 99 cents per share, which beat the Zacks Consensus Estimate of 95 cents. The bottom line increased 7.6% year over year. Total revenues of $940.1 million beat the Zacks Consensus Estimate of $939 million. The top line increased 1.3% year over year (up 1.6% at constant currency). (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Region-wise, Donaldson's net sales in the United States/Canada increased 0.9% year over year. The metric decreased 0.6% year over year in Europe, the Middle East and Africa, and increased 2.3% in Latin America. Also, net sales in the Asia Pacific improved 5.2%.Donaldson reports revenues under three segments, namely Mobile Solutions, Industrial Solutions and Life Sciences.A brief snapshot of segmental sales is provided Mobile Solutions segment's (accounting for 62% of net sales) sales were $582.6 million, indicating a year-over-year decline of 0.4%. Sales fell 8.3% in Off-Road and 24.5% in On-Road businesses during the quarter. Aftermarket sales improved 3.3% year over generated from the Industrial Solutions segment (30.1%) were $283.3 million, up 5.3% year over year. Industrial Filtration Solutions' sales increased 1.4% year over year. Sales growth of 27.1% in the Aerospace and Defense businesses also aided the generated from the Life Sciences segment (7.9%) were $74.2 million, up 0.7% year over year. The results benefited from continued volume growth in the Disk Drive business. Donaldson Company, Inc. price-consensus-eps-surprise-chart | Donaldson Company, Inc. Quote In the fiscal third quarter, Donaldson's cost of sales increased 3.4% year over year to $618.2 million. Gross profit declined 2.5% to $321.9 million. The gross margin of 34.2% declined 140 basis points, due to higher manufacturing expenses rose 25.7% year over year to $234.5 million. Operating profit decreased 39.1% to $87.4 million. The operating margin was 9.3%, down 620 bps year over effective tax rate was 33.6% compared with 21.2% in the year-ago quarter. Exiting the fiscal third quarter, Donaldson's cash and cash equivalents were $178.5 million compared with $232.7 million in the fourth quarter of fiscal 2024. Long-term debt was $638.8 million compared with $483.4 million in the fourth quarter of fiscal the first nine months of fiscal 2025, the company generated net cash of $251.0 million from operating activities, indicating a decrease of 31.5% year over year. Capital expenditure (net) totaled $58.6 million compared with $65.8 million in the year-ago fiscal period. Free cash flow decreased 36% to $192.4 million. In the same time frame, management repaid a long-term debt of $65 used $272.2 million to repurchase stocks and $96.9 million to pay out dividends during the first nine months of fiscal 2025. For fiscal 2025 (ending July 2025), Donaldson expects adjusted earnings per share to be in the range of $3.64-$3.70 compared with $3.42 in fiscal 2024. Sales are anticipated to increase 1- 3% from the fiscal 2024 level. Positive pricing is projected to have an accretive impact of 1%.On a segmental basis, Mobile Solutions' sales are expected to be flat to increase 2% from the fiscal 2024 level. Industrial Solutions' sales are envisioned to jump in the range of 2-4% from the year-ago figure. The company forecasts its Life Sciences segment's sales to increase in the high single-digit expenses are predicted to be approximately $23 million, while other income is projected to be in the range of $18-$20 million. The effective tax rate is anticipated to be between 23% and 24%.Capital expenditure is expected to be between $75 million and $90 million. Free cash flow conversion is anticipated to be in the range of 80-90%. The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. AZZ Inc. AZZ came out with quarterly earnings of 98 cents per share in the second quarter of fiscal 2025 (ended February 2025), beating the Zacks Consensus Estimate of 95 cents. This compares with earnings of 93 cents per share a year reported revenues of $351.9 million, missing the consensus estimate by 3.8%. This compares with year-ago revenues of $366.5 million. Valmont Industries VMI reported revenues of $969.3 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 remained flat year over reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per plc PNR came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of 94 cents per share a year reported revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.7%. This compares with year-ago revenues of $1.02 billion. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Valmont Industries, Inc. (VMI) : Free Stock Analysis Report AZZ Inc. (AZZ) : Free Stock Analysis Report Donaldson Company, Inc. (DCI) : Free Stock Analysis Report Pentair plc (PNR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y
HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y

Yahoo

time7 minutes ago

  • Yahoo

HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y

HealthEquity, Inc. HQY reported adjusted earnings per share (EPS) of 97 cents for first-quarter fiscal 2026, surpassing the Zacks Consensus Estimate by 19.8%. The bottom line improved 21.3% on a year-over-year basis. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.) GAAP EPS in the fiscal first quarter was 61 cents, up 84.8% compared with the year-ago quarter's EPS. Shares of HQY were up 5.8% in after-market trading following the earnings call. In the fiscal first quarter, the company generated revenues of $330.8 million, which beat the Zacks Consensus Estimate by 3%. The top line improved 15% from the prior-year quarter. As of April 30, 2025, the total number of Health Savings Accounts (HSAs) for which HealthEquity served as a non-bank custodian was 9.9 million, up 9% year over year. HealthEquity reported 770,000 HSAs with investments as of April 30, 2025, up 16% year over year. Total accounts, as of April 30, 2025, were 17.1 million, up 6.9% year over year. This uptick included total HSAs and 7.2 million Consumer Direct Benefits (CDBs), up 4.3% year over year. Total HSA assets were $31.3 billion at the end of April 30, 2025, up 15% year over year. This included $17.1 billion of HSA cash (up 7.5% year over year) and $14.2 billion of HSA investments (up 24.6% year over year). This figure compares to our fiscal first-quarter HSA cash and HSA investments projection of $18.3 billion and $13.5 billion, respectively. We had projected total HSA assets of $31.9 billion for the fiscal first quarter. Client-held funds, which are deposits held on behalf of HealthEquity's clients to facilitate the administration of its CDBs and from which the company generates custodial revenues, were $0.9 billion as of April 30, 2025. HealthEquity derives revenues from three sources: Service revenues, Custodial revenues, and Interchange revenues. Service revenues totaled $119.8 million in the quarter, up 1.3% year over year. This reflected a higher number of HSAs and invested HSA Assets. This figure compares favorably with our first-quarter projection of $121.9 million. Custodial revenues totaled $156.5 million, up 28.6% from the year-ago period. Our projection for the fiscal first-quarter Custodial revenues was $140.4 million. Interchange revenues totaled $54.6 million, up 14.4% year over year. This figure compares favorably with our fiscal first-quarter projection of $52 million. HealthEquity, Inc. price-consensus-eps-surprise-chart | HealthEquity, Inc. Quote In the quarter under review, HealthEquity's gross profit rose 19.9% to $224.3 million. The gross margin expanded 270 basis points (bps) to 67.8%. We had projected the gross margin to be 63.2% in the fiscal first quarter. Sales and marketing expenses rose 10.6% to $25.9 million year over year, whereas technology and development expenses climbed 9.5% year over year to $61.4 million. General and administrative expenses decreased 33.2% year over year to $25.5 million. Total operating expenses of $141.2 million decreased 2.9% year over year. Operating profit totaled $83.1 million, improving significantly by 99.6% from the prior-year quarter. The operating margin in the quarter expanded by a huge 1060 bps to 25.1% compared with the prior-year quarter. The company exited the first quarter of fiscal 2026 with cash and cash equivalents of $287.9 million compared with $295.9 million at the end of the fourth quarter of fiscal 2025. Total debt (net of issuance costs) at the end of first-quarter fiscal 2026 was $1.06 billion, flat compared with that at the end of fourth-quarter fiscal 2025. Net cash provided by operating activities at the end of first-quarter fiscal 2026 totaled $64.7 million compared with $65.4 million a year ago. HealthEquity has reiterated its revenue and updated its EPS projections for fiscal 2026. For fiscal 2026, revenues are projected to be between $1.285 billion and $1.305 billion. The Zacks Consensus Estimate is currently pegged at $1.30 billion. Adjusted EPS is now expected to be in the range of $3.61-$3.78 as compared with the previous guidance of $3.57-$3.74. The Zacks Consensus Estimate currently stands at $3.60. HealthEquity exited first-quarter fiscal 2026 with better-than-expected results. The company witnessed solid top-line and bottom-line performances in the reported quarter. Solid growth in HSAs also drove the top line. The solid uptick in total HSA assets in the reported quarter is promising. Significant improvement in the operating and gross margins also bodes well. The company added 150,000 new HSAs during the quarter and maintained strong enterprise pipeline momentum despite macroeconomic pressures. Per management, fraud-related costs dropped significantly from $11 million in the fourth quarter of fiscal 2025 to $3 million in the reported quarter, thanks to AI-powered tools and enhanced mobile security, boosting margins and member trust. Management raised full-year guidance and reiterated confidence in further margin normalization, growth from legislative tailwinds, and strong client retention, positioning HQY for sustained growth and operational strength. However, fraud-related costs, though significantly reduced, still stood at $3 million, which management acknowledged as still elevated. While this reflects major improvement from the prior quarter's $11 million, it highlights that fraud remains a lingering operational risk. Management is targeting to bring fraud costs down to 1 basis point of total HSA assets. Currently, HealthEquity carries a Zacks Rank #2 (Buy). Some other top-ranked stocks in the broader medical space that have announced quarterly results are CVS Health Corporation CVS, Integer Holdings Corporation ITGR and AngioDynamics ANGO. CVS Health, carrying a Zacks Rank of 2, reported first-quarter 2025 adjusted earnings per share (EPS) of $2.25, beating the Zacks Consensus Estimate by 31.6%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Revenues of $94.59 billion outpaced the consensus mark by 1.8%. CVS Health has a long-term estimated growth rate of 11.4%. Its earnings surpassed estimates in each of the trailing four quarters, with an average surprise of 18.1%. Integer Holdings reported first-quarter 2025 adjusted EPS of $1.31, beating the Zacks Consensus Estimate by 3.2%. Revenues of $437.4 million surpassed the Zacks Consensus Estimate by 1.3%. It currently sports a Zacks Rank of 1. Integer Holdings has a long-term estimated growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%. AngioDynamics, currently sporting a Zacks Rank #1, reported a third-quarter fiscal 2025 adjusted EPS of 3 cents against the Zacks Consensus Estimate of a 13-cent loss. Revenues of $72 million beat the Zacks Consensus Estimate by 2%. ANGO has an estimated fiscal 2026 earnings growth rate of 27.8% compared with the S&P 500 Composite's 10.5% growth. AngioDynamics' earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 70.9%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AngioDynamics, Inc. (ANGO) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store